Bone marrow-derived lin-c-kit+Sca-1+ stem cells do not contribute to vasculogenesis in Lewis lung carcinoma

Neoplasia

Volumn 7, Issue 3, 2005, Pages 234-240

  Patil, Vivek R Shinde ^a   Friedrich, Erik B ^a   Wolley, Allison E ^a   Gerszten, Robert E ^a   Allport, Jennifer R ^a   Weissleder, Ralph ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Angiogenesis; Chemokine; Stem cells; Tumors; Vasculogenesis

Indexed keywords

CHEMOKINE;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; B LYMPHOCYTE ACTIVATION; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; ENDOTHELIUM CELL; EXPERIMENTAL MODEL; IMPLANTATION; LEWIS CARCINOMA; LIN C KIT SCA1 STEM CELL; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NERVE SPROUTING; NONHUMAN; PRIORITY JOURNAL; STEM CELL; TUMOR BLOOD FLOW; TUMOR GROWTH;

EID: 15744390070     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1593/neo.04523     Document Type: Article

References (32)

1. Carmeliet P (2003). Angiogenesis in health and disease. Nat Med 9, 653-660.
2. Hanahan D and Folkman J (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364.
3. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, and Isner JM (1999). Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85, 221-228.
4. Davidoff AM, Ng CY, Brown P, Leary MA, Spurbeck WW, Zhou J, Horwitz E, Vanin EF, and Nienhuis AW (2001). Bone marrow-derived cells contribute to tumor neovasculature and, when modified to express an angiogenesis inhibitor, can restrict tumor growth in mice. Clin Cancer Res 7, 2870-2879.
5. Garcia-Barros M, Paris F, Cordon-Cardo C, Lyden D, Rafii S, Haimovitz-Friedman A, Fuks Z, and Kolesnick R (2003). Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300, 1155-1159.
6. Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L, Chadburn A, Heissig B, Marks W, Witte L, et al. (2001). Impaired recruitment of bone marrow-de rived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 7, 1194-1201.
7. Moore MA (2002). Putting the neo into neoangiogenesis. J Clin Invest 109, 313-315.
8. Reyes M, Dudek A, Jahagirdar B, Koodie L, Marker PH, and Verfaillie CM (2002). Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 109, 337-346.
9. Ruzinova MB, Schoer RA, Gerald W, Egan JE, Pandolfi PP, Rafii S, Manova K, Mittal V, and Benezra R (2003). Effect of angiogenesis inhibition by 1d loss and the contribution of bone marrow-derived endothelial cells in spontaneous murine tumors. Cancer Cell 4, 277-289.
10. De Palma M, Venneri MA, Roca C, and Naldini L (2003). Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat Med 9, 789-795.
11. Gothert JR, Gustin SE, Van Eekelen AM, Schmidt U, Hall MA, Jane SM, Green AR, Gottgens B, Izon DJ, and Begley CG (2004). Genetically tagging endothelial cells in vivo: bone marrow-derived cells do not contribute to tumor endothelium. Blood 104, 1769-1777.
12. Bhattacharya V, McSweeney PA, Shi Q, Bruno B, Ishida A, Nash R, Storb RF, Sauvage LR, Hammond WP, and Wu MH (2000). Enhanced endothelialization and microvessel formation in polyester grafts seeded with CD34(+) bone marrow cells. Blood 95, 581-585.
13. Crisa L, Cirulli V, Smith KA, Ellisman MH, Torbett BE, and Salomon DR (1999). Human cord blood progenitors sustain thymic T-cell development and a novel form of angiogenesis. Blood 94, 3928-3940.
14. Grant MB, Caballero S, Brown GA, Guthrie SM, Mames RN, Vaught T, and Scott EW (2003). The contribution of adult hematopoietic stem cells to retinal neovascularization. Adv Exp Med Biol 522, 37-45.
15. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, Li T, Isner JM, and Asahara T (2000). Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 97, 3422-3427.
16. Orlic D, Kajstura J, Chimenti S, Bodine DM, Leri A, and Anversa P (2003). Bone marrow stem cells regenerate infarcted myocardium. Pediatr Transplant 7 (Suppl 3), 86-88.
17. Otani A, Kinder K, Ewalt K, Otero FJ, Schimmel P, and Friedlander M (2002). Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis. Nat Med 8, 1004-1010.
18. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, and Asahara T (1999). Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5, 434-438.
19. Rafii S and Lyden D (2003). Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 9, 702-712.
20. Rafii S, Lyden D, Benezra R, Hattori K, and Heissig B (2002). Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? Nat Rev Cancer 2, 826-835.
21. Vajkoczy P, Blum S, Lamparter M, Mailhammer R, Erber R, Engelhardt B, Vestweber D, and Hatzopoulos AK (2003). Multistep nature of microvascular recruitment of ex vivo-expanded embryonic endothelial progenitor cells during tumor angiogenesis. J Exp Med 197, 1755-1765.
22. Wei J, Blum S, Unger M, Jarmy G, Lamparter M, Geishauser A, Vlastos GA, Chan G, Fischer KD, Rattat D, et al. (2004). Embryonic endothelial progenitor cells armed with a suicide gene target hypoxic lung metastases after intravenous delivery. Cancer Cell 5, 477-488.
23. Rafii S, Heissig B, and Hattori K (2002). Efficient mobilization and recruitment of marrow-derived endothelial and hematopoietic stem cells by adenoviral vectors expressing angiogenic factors. Gene Ther 9, 631-641.
24. Aicher A, Heeschen C, Mildner-Rihm C, Urbich C, Ihling C, Technau-Ihling K, Zeiher AM, and Dimmeler S (2003). Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 9, 1370-1376.
25. Duda DG, Fukumura D, and Jain RK (2004). Role of eNOS in neovascularization: NO for endothelial progenitor cells. Trends Mol Med 10, 143-145.
26. Allport JR, Shinde Patil VR, and Weissleder R (2004). Murine neuronal progenitor cells are preferentially recruited to tumor vasculature via a4-integrin and SDF-1a dependent mechanisms. Cancer Biol Ther 3, 838-844.
27. Zhu H, Melder RJ, Baxter LT, and Jain RK (1996). Physiologically based kinetic model of effector cell biodistribution in mammals: implications for adoptive immunotherapy. Cancer Res 56, 3771-3781.
28. Allport JR, Muller WA, and Luscinskas FW (2000). Monocytes induce reversible focal changes in vascular endothelial cadherin complex during transendothelial migration under flow. J Cell Biol 148, 203-216.
29. Asahara T (2003). Endothelial progenitor cells for neovascularization. Ernst Schering Res Found Workshop, 211-216.
30. Rafii S, Avecilla S, Shmelkov S, Shido K, Tejada R, Moore MA, Heissig B, and Hattori K (2003). Angiogenic factors reconstitute hematopoiesis by recruiting stem cells from bone marrow microenvironment. Ann NY Acad Sci 996, 49-60.
31. Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT, and Weissleder R (2000). Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 18, 410-414.
32. Kircher MF, Allport JR, Graves EE, Love V, Josephson L, Lichtman AH, and Weissleder R (2003). In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors. Cancer Res 63, 6838-6846.